Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¹æ»ç¼± Á¶»ç ÈÄ ¹ß»ýÇÑ ÈòÁã ½ÉÀå¼Õ»ó¿¡¼­ CaptoprilÀÇ ¹æ¾î¿ªÇÒ°ú ±âÀü The Radioprotective Effect and Mechanism of Captopril on Radiation Induced-Heart Damage in Rats

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2004³â 22±Ç 1È£ p.40 ~ 54
¼Ò¼Ó »ó¼¼Á¤º¸
Àå½ÂÈñ/Chang SH ÀÌ°æÀÚ/±¸Çý¼ö

Abstract

¸ñ Àû: Á¤»ó ÈòÁãÀÇ ½ÉÀå¿¡ ¹æ»ç¼±À» Á¶»çÇÑ ±º°ú captopril°ú ¹æ»ç¼± Á¶»ç¸¦ º´¿ëÇÑ ±ºÀÇ º´¸®ÇÐÀû ¼Ò°ß°ú TNF-¥á(tumor necrosis factor-alpha), TGF-¥â1 (transforming growth factor-beta), PDGF (platelet-derived growth factor), FGF (fibroblast growth factor)-2ÀÇ ¹ßÇö»óŸ¦ ºñ±³ °üÂûÇÔÀ¸·Î½á ½ÉÀåÀÇ Á¶±â ¹æ»ç¼±¼Õ»ó¿¡¼­ captoprilÀÇ È¿°ú¿Í º¸È£±âÀü¿¡¼­ÀÇ »çÀÌÅäÄ«ÀÎÀÇ ¿ªÇÒÀ» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý: ½ÇÇ赿¹°(Sprague-Dawley ÈòÁã)Àº ´ëÁ¶±º, ¹æ»ç¼± Á¶»ç ´Üµ¶±º, captopril°ú ¹æ»ç¼± Á¶»ç º´¿ë±ºÀ¸·Î ºÐ·ùÇÏ¿´´Ù. ¹æ»ç¼± Á¶»ç ´Üµ¶±ºÀº 12.5 GyÀÇ X-¼±À» ÁÂÈä°û¿¡ ´ÜÀÏ Á¶»çÇÏ¿´´Ù. Captopril°ú ¹æ»ç¼± Á¶»ç º´¿ë±ºÀº 1ÀÏ 50 mg/kgÀÇ captoprilÀ» ¹æ»ç¼±Á¶»ç 1ÁÖ ÀüºÎÅÍ ½ÇÇèÁ¾·á ½ÃÀÎ 8ÁÖ ÈıîÁö ½Ä¼ö¿¡ ¼¯¾î À½¿ë½ÃÄ×´Ù. ½ÇÇè °á°ú´Â ¹æ»ç¼±Á¶»ç 2ÁÖ¿Í 8ÁÖ ÈÄ¿¡ ½É¹æ°ú ½É½ÇÀÇ º´¸®Á¶Á÷ ¼Ò°ßÀ» ºñ±³ °üÂûÇÏ¿´°í ¸é¿ªÁ¶Á÷È­Çп°»öÀ¸·Î TNF-¥á, TGF-¥â1, PDGF, FGF-2ÀÇ ¹ßÇöÀ» °üÂûÇÏ¿´´Ù.

°á °ú: ¹æ»ç¼±Á¶»ç 2ÁÖ ÈÄ º´¸®Á¶Á÷ ¼Ò°ß»ó ´ëÁ¶±º¿¡ ºñÇØ ½ÉÇÑ ½É¹æ ½ÉÀ帷(pericardium) ¼¶À¯¼Ò ħÂø(p=0.093), ½É½Ç Ç÷°üÁÖÀ§(perivascular space) ºÎÁ¾(p=0.082)°ú Ç÷°üÁÖÀ§ ¹× »çÀÌÁú(interstitium)ÀÇ ¼¶À¯¼Ò ħÂø(p=0.018)ÀÌ º¸¿´À¸¸ç, ½É¹æ ½ÉÀ帷ÀÇ ¼¶À¯¼Ò ħÂøÀº ½É½Ç¿¡ ºñÇØ ÇöÀúÇÏ¿´´Ù(p=0.009). ¹æ»ç¼± Á¶»ç ÈÄ 8ÁÖÀÇ º¯È­´Â 2ÁÖ ¼Ò°ß¿¡ ºñÇؼ­ ºÎÁ¾ ¹× ¼¶À¯¼Ò ħÂøÀº ¼Ò¸êµÇ¾ú°í, ¼¶À¯È­°¡ °üÂûµÇ¾ú´Âµ¥ ÀÌ´Â ½É½Çº¸´Ù ½É¹æÀÇ ½ÉÀ帷¿¡¼­ ÇöÀúÇÏ°Ô ³ªÅ¸³µ´Ù. Captopril°ú ¹æ»ç¼± º´¿ë±ºÀº ¹æ»ç¼±¿¡ ÀÇÇÑ ½ÉÀå¼Õ»óÀÌ °¨¼ÒµÇ¾î º´¸®ÇÐÀû ¼Ò°ß»ó ´ëÁ¶±º°ú ºñ±³ ½Ã À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø¾ú°í, ¹æ»ç¼± Á¶»ç ´Üµ¶±º°ú ºñ±³ÇÏ¿© ƯÈ÷ 2ÁÖ ÈÄ¿¡ ½É¹æÀÇ ½É³»¸·(endocardium) ¼¶À¯¼Ò ħÂø(p=0.047)°ú ½É½ÇÀÇ »çÀÌÁú ¼¶À¯¼Ò ħÂø(p=0.019) ¹× ºÎÁ¾(p=0.042)ÀÌ ÇöÀúÈ÷ °¨¼ÒµÇ¾ú´Ù. ¹æ»ç¼±Á¶»ç 2ÁÖ ÈÄ¿¡ TNF-¥á, TGF-¥â1, PDGF, FGF-2ÀÇ ¹ßÇöÀÌ ¹æ»ç¼± Á¶»ç ´Üµ¶±º¿¡¼­ ´ëÁ¶±º°ú ºñ±³ÇÏ¿© Áõ°¡µÇ¾úÀ¸¸ç, ƯÈ÷ ½É¹æÀÇ ½ÉÀ帷 ¹× ½ÉÀå³»¸·¿¡¼­ ÇöÀúÇÏ°Ô Áõ°¡µÇ¾ú´Ù. ¹æ»ç¼±Á¶»ç 8ÁÖ ÈÄ¿¡´Â ½ÉÀ帷ÀÇ TNF-¥á, TGF-¥â1ÀÌ °è¼Ó Áõ°¡µÇ¾úÀ¸¸ç TGF-¥â1´Â ½É¹æ ½É³»¸·(p=0.015)°ú »çÀÌÁú(p=0.025)¿¡¼­ ƯÈ÷ Áõ°¡µÇ¾úÀ¸³ª, PDGF¿Í FGF-2´Â °¨¼ÒµÇ¾ú´Ù. Captopril°ú ¹æ»ç¼± Á¶»ç º´¿ë±ºÀº 2ÁÖ¿¡ ¹æ»ç¼± Á¶»ç ´Üµ¶±º¿¡ ºñÇÏ¿© TNF-¥á, TGF-¥â1, PDGFÀÇ ¹ßÇöÀÌ °¨¼ÒµÇ¾úÀ¸¸ç, 8ÁÖ¿¡´Â ½É¹æ°ú ½É½ÇÀÇ ½ÉÀ帷¿¡¼­ TNF-¥á°¡ ÇöÀúÈ÷ °¨¼ÒµÇ¾ú°í(p=0.049, p=0.009) TGF-¥â1, PDGFÀÇ °æ¿ì °¨¼ÒµÇ´Â °æÇâÀ» º¸¿´À¸³ª À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù.

°á ·Ð: ÈòÁãÀÇ ½ÉÀå¿¡ captoprilÀ» ¹æ»ç¼±°ú º´¿ë Åõ¿©ÇÏ¿© º´¸®Á¶Á÷ ¼Ò°ßÀ» °üÂûÇÑ °á°ú ¹æ»ç¼±¿¡ ÀÇÇÑ Á¶±â ½ÉÀå¼Õ»óÀÌ °¨¼ÒµÊÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù. ¶ÇÇÑ ¹æ»ç¼±Á¶»ç ÈÄ 2ÁÖ ¹× 8ÁÖ¿¡ º´¿ë±º¿¡¼­ ´Üµ¶±º¿¡ ºñÇÏ¿© TNF-¥á, TGF-¥â1, PDGF µîÀÇ ¹ßÇöÀÌ °¨¼ÒÇÏ´Â ¾ç»óÀÌ °üÂûµÇ¾î, captoprilÀÌ »çÀÌÅäÄ«ÀÎÀÇ ¹ßÇöÀ» ¾ïÁ¦ÇÔÀ¸·Î½á ¹æ»ç¼±¿¡ ÀÇÇÑ ½ÉÀå¼Õ»óÀ» °¨¼Ò½Ãų ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢µÈ´Ù.

Purpose: Captopril (angiotension converting enzyme inhibitor) is known to have a radioprotective effect in the lungs, intestines and skin, but its effect in the heart is unclear. To investigate the radioprotective effect and mechanism of captopril in the heart, the histopathological changes and immunohistochemical stains were compared with radiation alone, and radiation combined with captopril, in the rats.

Materials and Methods: The histopathological changes and immunohistochemical stains (TNF¥á, TGF¥â1, PDGF and FGF2) were examined in the radiation alone and the combined captopril and radiation groups, 2 and 8 weeks after irradiation. Each group consisted of 8 to 10 rats (Sprague-Dawley). Irradiation (12.5 Gy) was given to the left hemithorax in a single fraction. Captopril (50 mg/Kg/d) mixed with water, was given orally and continuously from the first week prior to, up to the 8th week of the experiment.

Results: In the radiation alone group, the ventricle at 2 weeks after irradiation showed prominent edema (p=0.082) and fibrin deposit (p=0.018) compared to the control group. At 8 weeks, the edema was decreased and fibrosis increased compared to those at 2 weeks. The histopathological changes of the combined group were similar to those of the control group, due to the reduced radiation toxicity at 2 and 8 weeks. The endocardial fibrin deposit (p=0.047) in the atrium, and the interstitial fibrin deposit (p=0.019) and edema (p=0.042) of the ventricle were reduced significantly in the combined group compared to those in the radiation alone group at 2 weeks. The expressions of TNF-¥á, TGF-¥â1, PDGF and FGF-2 in the radiation alone group were more increased than in the control group, especially in the pericardium and endocardium of the atrium at 2 weeks. At 8 weeks, the pericardial TNF-¥á and TGF-¥â1 in the radiation alone group continuously increased. The expressions of TNF-¥á, TGF-¥â1 and PDGF were decreased in the combined group at 2 weeks. At 8 weeks, the expressions of TNF-¥á in the atrial and ventricular pericardia were markedly reduced (p=0.049, p=0.009).

Conclusion: This study revealed that the early heart damage induced by radiation can be reduced by the addition of captopril in a rat model. The expressions of TNF-¥á, TGF-¥â1 and PDGF were further decreased in the combined compared to the radiation alone group at both 2 and 8 weeks. From these results, it may be concluded that these cytokines probably play roles in the radioprotective mechanism of captopril from the radiation-induced heart toxicity, similarly to in other organs.



Å°¿öµå

Captopril;¹æ»ç¼±º¸È£Á¦;½ÉÀå;Captopril;Radioprotector;Heart

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS